These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37944596)

  • 21. Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation.
    Siegel S; Noblett K; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Thiery E
    Urology; 2016 Aug; 94():57-63. PubMed ID: 27131966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM; Carrico DJ; MacDiarmid SA; Wooldridge LS; Khan AU; McCoy CE; Franco N; Bennett JB
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome.
    Kobashi K; Nitti V; Margolis E; Sand P; Siegel S; Khandwala S; Newman D; MacDiarmid SA; Kan F; Michaud E
    Urology; 2019 Sep; 131():77-82. PubMed ID: 31199966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.
    Komesu YM; Amundsen CL; Richter HE; Erickson SW; Ackenbom MF; Andy UU; Sung VW; Albo M; Gregory WT; Paraiso MF; Wallace D;
    Am J Obstet Gynecol; 2018 Jan; 218(1):111.e1-111.e9. PubMed ID: 29031894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S; Kabay S; Mestan E; Cetiner M; Ayas S; Sevim M; Ozden H; Karaman HO
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
    Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
    Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE study.
    Goudelocke C; Xavier K; Pecha B; Burgess K; Perrouin-Verbe MA; Krlin R; Michaels J; Shah S; Peyronnet B; Zaslau S; Champs M; Papi B; Bittner K; Elterman D; Nitti V
    Neurourol Urodyn; 2023 Apr; 42(4):761-769. PubMed ID: 36917003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial.
    Wagner L; Alonso S; Le Normand L; Faix A; Kabani S; Castelli C; Gamé X; Cornu JN; Bey E
    Neurourol Urodyn; 2020 Nov; 39(8):2230-2237. PubMed ID: 32835443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bladder training for treating overactive bladder in adults.
    Funada S; Yoshioka T; Luo Y; Sato A; Akamatsu S; Watanabe N
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013571. PubMed ID: 37811598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Sacral Neuromodulation in Patients with Prior Surgical Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse.
    Bartley JM; Ramirez V; Killinger KA; Boura JA; Gupta P; Gaines N; Gilleran JP; Peters KM
    Female Pelvic Med Reconstr Surg; 2017; 23(1):8-12. PubMed ID: 27636222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.
    Richter HE; Moalli P; Amundsen CL; Malykhina AP; Wallace D; Rogers R; Myers D; Paraiso M; Albo M; Shi H; Nolen T; Meikle S; Word RA;
    J Urol; 2017 Jun; 197(6):1487-1495. PubMed ID: 28089729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical electrical stimulation treatment for overactive bladder: An observational study.
    Yune JJ; Shen JK; Pierce MA; Hardesty JS; Kim J; Siddighi S
    Investig Clin Urol; 2018 Jul; 59(4):246-251. PubMed ID: 29984339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.
    Harvie HS; Amundsen CL; Neuwahl SJ; Honeycutt AA; Lukacz ES; Sung VW; Rogers RG; Ellington D; Ferrando CA; Chermansky CJ; Mazloomdoost D; Thomas S
    J Urol; 2020 May; 203(5):969-977. PubMed ID: 31738113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder.
    Sirls LT; Schonhoff A; Waldvogel A; Peters KM
    Neurourol Urodyn; 2023 Feb; 42(2):427-435. PubMed ID: 36573835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonics® system for treatment of overactive bladder syndrome and urinary urgency incontinence.
    Wang A; Rourke E; Sebesta E; Dmochowski R
    Expert Rev Med Devices; 2021 Aug; 18(8):727-732. PubMed ID: 34187274
    [No Abstract]   [Full Text] [Related]  

  • 38. Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study.
    Chartier-Kastler E; Le Normand L; Ruffion A; Dargent F; Braguet R; Saussine C; Tanneau Y; Graziana JP; Ragni E; Rabut B; Rousseau T; Biardeau X; Gamé X; Pierrevelcin J; Brassart E; Fourmarier M; Stoica G; Berrogain N; Yaghi N; Pecoux F; Capon G; Ferchaud J; Peyrat L; Bryckaert PE; Karsenty G; Melotti A; Abouihia A; Keller DUJ; Cornu JN
    Eur Urol Focus; 2021 Nov; 7(6):1430-1437. PubMed ID: 32907782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective, multicenter study to evaluate performance and safety of a re-engineered temporary lead for InterStim™ therapy evaluation.
    Elterman D; Michaels J; Margolis E; Harris-Hicks J; Burgess K; Betts C; Harding C; Towers G; Hashim H; Ojo-Carons A; White A; Cannon-Smith T; Grunow N; Bittner K; Xavier K
    Neurourol Urodyn; 2022 Nov; 41(8):1731-1738. PubMed ID: 35900298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system.
    Pezzella A; McCrery R; Lane F; Benson K; Taylor C; Padron O; Blok B; de Wachter S; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman HB
    Neurourol Urodyn; 2021 Feb; 40(2):714-721. PubMed ID: 33508155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.